The DOI matches its Crossref record; 312 of the 321 references it cites were found in a registry or an index.
Allergen injection immunotherapy for seasonal allergic rhinitis
Open accessAbstract
BACKGROUND: Allergic rhinitis is the most common of the allergic diseases. Despite improved understanding of the pathophysiology of allergic rhinitis and advances in its pharmacological treatment, its prevalence has increased worldwide. For patients whose symptoms remain uncontrolled despite medical treatment, allergen injection immunotherapy is advised. An allergen-based treatment may reduce symptoms, the need for medication and modify the natural course of this disease. OBJECTIVES: To evaluate the efficacy and safety of subcutaneous specific allergen immunotherapy, compared with placebo, for reducing symptoms and medication requirements in seasonal allergic rhinitis patients. SEARCH STRATEGY: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 1 2006), MEDLINE (1950 to 2006), EMBASE (1974 to 2006), Pre-MEDLINE, KOREAMED, INDMED, LILACS, PAKMEDINET, Scisearch, mRCT and the National Research Register. The date of the last search was February 2006. SELECTION CRITERIA: All studies identified by the searches were assessed to identify randomised controlled trials involving participants with symptoms of seasonal allergic rhinitis and proven allergen sensitivity, treated with subcutaneous allergen specific immunotherapy or corresponding placebo. DATA COLLECTION AND ANALYSIS: Two independent authors identified all studies reporting double-blind, placebo controlled randomised trials of specific immunotherapy in patients with seasonal allergic rhinitis due to tree, grass or weed pollens. Two authors independently performed quality assessment of studies. Data from identified studies were abstracted onto a standard extraction sheet and subsequently entered into RevMan 4.2.8. Analysis was performed using the Standardised Mean Difference (SMD) method and a random-effects model; P values < 0.05 were considered statistically significant. The primary outcome measures were symptom scores, medication use, quality of life and adverse events. MAIN RESULTS: We retrieved 1111 publications of which 51 satisfied our inclusion criteria. In total there were 2871 participants (1645 active, 1226 placebo), each receiving on average 18 injections. Duration of immunotherapy varied from three days to three years. Symptom score data from 15 trials were suitable for meta-analysis and showed an overall reduction in the immunotherapy group (SMD -0.73 (95% CI -0.97 to -0.50, P < 0.00001)). Medication score data from 13 trials showed an overall reduction in the immunotherapy group (SMD of -0.57 (95% CI -0.82 to -0.33, p<0.00001)). Clinical interpretation of the effect size is difficult. Adrenaline was given in 0.13% (19 of 14085 injections) of those on active treatment and in 0.01% (1 of 8278 injections) of the placebo group for treatment of adverse events. There were no fatalities. AUTHORS' CONCLUSIONS: This review has shown that specific allergen injection immunotherapy in suitably selected patients with seasonal allergic rhinitis results in a significant reduction in symptom scores and medication use. Injection immunotherapy has a known and relatively low risk of severe adverse events. We found no long-term consequences from adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Total symptom score is the main variable in systematic reviews and meta-analyses, both in SCIT [172] and in SLIT in drops [173] or in tablets [174]; therefore, specific data on NO are not usually published [171].”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Beasley, R. W. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07302-9 · Cited by 3,794
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R. F., & Malling, H. ‐. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,582
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E., Jacobson, M. R., O'Brien, F., Noble, W. J., Till, S. J., Hamid, Q. A., & Nouri‐Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,371
Self-citationMöller, C., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Jacobsen, L., Koivikko, A., Koller, D. Y., Niggemann, B., Norberg, L. A., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121317 · Cited by 1,065
Flagged first, then by citations
9 of the 321 references couldn’t be matched to a known paper.
Research works printed but not linked: 29
- Brewczynski, 1999, Efficacy and safety of immunotherapy with modified grass pollen allergens. Results of a placebo-controlled study, Allergologie, 22, 411
- Hauser, 1995, Inhibitory effect on migration of inflammatory cells into the nasal mucosa by immunotherapy, Allergo Journal, 4, 164
- Berstein, 2001, Double blind placebo controlled (DBPC) study of grapeseed extract in the treatment of seasonal allergic rhinitis (SAR), Journal of Allergy and Clinical Immunology, 107, S311
- Calderon, 2003, Double blind placebo controlled study of specific immunotherapy (SIT) with Alutard SQ grass pollen for seasonal allergic rhinoconjunctivitis, Allergy and Clinical Immunology International, 1, Abstract No. O-
- Crimi, 2001, A randomised double-blind study of specific immunotherapy (SIT) in patients with seasonal allergic-rhinitis: effects on clinical and inflammatory markers, European Respiratory Journal, 18, 482s
- Egger, 1997, The influence of hypo-sensitisation therapy on the sense of smell in subjects with seasonal allergic rhinitis, Allergologie, 20, 525
- Frankland, 1963, Treatment of hay fever by depot injection (shypyrindene) in allergic conditions. Double blind clinical study, Acta Allergologica, 18, 175
- Kerr, 1964, The treatment of hay fever including a controlled trial of the use of alum precipitate pollen adsorbate, Acta Allergologica, 19, 76
- Kuhn, 1985, Hyposensitization in pollen sensitive children: A 3 year prospective study, Allergologie, 8, 103
- Lindsay-Miller, 1971, Pollen Tyrosine in the treatment of hay fever, Clinical Allergy, 1, 351
- Malling, 2000, Allergen specific immunotherapy for asthma, Ugeskr Laeger, 162 (4), 477
- Manger, 1984, Hyposensitization of hay fever patients with Tyrosin-adsorbed grass and rye pollen allergoid. Clinical and immunological parameters during different dosages with TA Tyrosin-Allergoid Gräserpollen, Allergologie, 7, 222
- Mewes, 1999, Short term immune therapy with ALK7 reduces grass-pollen induces rhinoconjunctivitis symptoms and the specific nasal reactivity is more efficient than a symptomatic standard therapy, Allergologie, 22, 581
- Nolte, 1999, Allergen extracts, dosing, efficacy and safety of immunotherapy, International Review of Allergology and Clinical Immunology, 5 (3), 184
- Osterballe, 1982, Immunotherapy in hay fever with timothy major allergens, Allergy, 37, 8
- Pastorello, 1988, A double blind placebo controlled trial of specific immunotherapy with aluminium hydroxide adsorbed allergoid in grass pollen induced rhinitis, Allergy, 43, 48
- Ricca, 1997, Preseasonal specific immunotherapy with modified Phleum pratense allergenic extracts: tolerability and effects, Allergologia et Immunopathologia (Madrid), 25, 167
- Rozniecka, 1995, The characteristics of pollinosis during the pollen season and the influence of specific immunotherapy. Part II: Cytologic changes and chemotactic activity in nasal lavage, Pneumonologia i Alergologia Polska, 63, 144
- Ruiz, 2001, Safety and efficacy of immunotherapy with a standardized depigmented and glutaraldehyde-polyerized extract of phleum pratense pollen, Journal of Allergy and Clinical Immunology, 107, S260
- Sandstrom, 2001, Xolair is effective in the treatment of seasonal birch pollen allergic rhinitis, Annals of Allergy, Asthma and Immunology, 86, 83
- Stuck, 2001, Birch pollen allergoid plus MPL in short-term immunotherapy, Otolaryngology - Head and Neck Surgery, 125, P199
- Sykora, 2004, Efficacy and safety of specific allergen immunotherapy with standardized depod allergen H-AI depot (pollens), Alergie, 6, 170
- Watanabe, 2003, Successful grass pollen immunotherapy inhibits eosinophil accumulation in the nasal mucosa: role of adhesion molecules and apoptosis [Abstract], Allergy and Clinical Immunology International, 15, Abstract No.O-1
- Williams, 2001, A study to determine the efficacy of a nasally administered rye grass peptide, Ptl-0901, in the treatment of severe seasonal hayfever, Journal of Allergy and Clinical Immunology, 107, S256
- Williams, 2002, Effectiveness of preseasonal allergoid immunotherapy in patients with grass pollen allergy [Abstract], Allergy, 57, 51
- Yariktas, 2002, Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis, Turkish Archives of Otolaryngology, 40, 252
- Frank, 2001, Effectiveness of a pre-seasonal allergoid immunotherapy in patients with seasonal allergic rhinitis due to grass pollen, Journal of Allergy and Clinical Immunology, 107, S260
- Committee of the Safety of Medicine, 1994, Desensitising vaccines: New advice, Current Problems in Pharmacovigilance, 20, 5
- Durham, 1999, Long-term clinical efficacy of grass-pollen immunotherapy, New England Journal of Medicine, 341(7), 468, 10.1056/NEJM199908123410702 · DOI
Cited by
Sorted by citations
Items 201–300 of 674
Rosewich, M. (2009) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2009.00953.x · Cited by 32
Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines
Aboshady, O. A., & Elghanam, K. M. (2014) · Clinical and Experimental Otorhinolaryngology · doi:10.3342/ceo.2014.7.4.241 · Cited by 32
Huang, Y., Wang, C., Cao, F., Zhao, Y., Lou, H., & Zhang, L. (2018) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2019.11.1.68 · Cited by 32
One Century of Allergen-Specific Immunotherapy for Respiratory Allergy
Incorvaia, C., & Frati, F. (2011) · Immunotherapy · doi:10.2217/imt.11.36 · Cited by 31
Role of immunotherapy in the treatment of allergic asthma
Yükselen, A. (2014) · World Journal of Clinical Cases · doi:10.12998/wjcc.v2.i12.859 · Cited by 31
Specific immunotherapy in allergic rhinitis
Mortuaire, G., Michel, J., Papon, J., Malard, O., Ebbo, D., Crampette, L., Jankowski, R., Coste, A., & Serrano, É. (2017) · European Annals of Otorhinolaryngology Head and Neck Diseases · doi:10.1016/j.anorl.2017.06.005 · Cited by 31
Adherence in allergen immunotherapy: Current situation and future implications
Gehrt, F., Xu, Q., Baiardini, I., Canonica, G. W., & Pfaar, O. (2022) · Allergologie select · doi:10.5414/alx02318e · Cited by 31
Apolipoprotein A-IV is a candidate target molecule for the treatment of seasonal allergic rhinitis
Makino, Y., Noguchi, E., Takahashi, N., Matsumoto, Y., Kubo, S., Yamada, T., Imoto, Y., Ito, Y., Osawa, Y., Shibasaki, M., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.031 · Cited by 31
Specific immunotherapy and turning off the T cell: how does it work?
Özdemir, C., Küçüksezer, U. C., Akdiş, M., & Akdiş, C. A. (2011) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2011.05.017 · Cited by 31
Moos, S. C. V., Kündig, T. M., & Senti, G. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.02.012 · Cited by 31
Didier, A. P., Chartier, A., & Démonet, G. (2010) · Revue française d'allergologie · doi:10.1016/j.reval.2010.07.001 · Cited by 31
Mackenzie, K. J., Fitch, P. M., Leech, M. D., Ilchmann, A., Wilson, C., McFarlane, A. J., Howie, S., Anderton, S. M., & Schwarze, J. (2012) · Immunology · doi:10.1111/imm.12032 · Cited by 30
Specific allergen immunotherapy for the treatment of allergic asthma: a review of current evidence
Domínguez‐Ortega, J., Delgado, J., Blanco, C., Prieto, L. M., Arroabarren, E., Cimarra, M., Henríquez‐Santana, A., Iglesias-Souto, J., Vega‐Chicote, J. M., & Tabar, A. I. (2017) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0149 · Cited by 30
Helminth therapy (worms) for allergic rhinitis
Croft, A. M., Bager, P., & Garg, S. K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009238.pub2 · Cited by 30
New visions in specific immunotherapy in children: an iPAC summary and future trends
Halken, S., Lau, S., & Valovirta, E. J. (2008) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2008.00768.x · Cited by 30
Multiallergen-Specific Immunotherapy in Polysensitized Patients: where Are we?
Bahçeciler, N. N., Galip, N., & Çobanoğlu, N. (2013) · Immunotherapy · doi:10.2217/imt.12.161 · Cited by 29
Clinical Relevance of IgE to Profilin and/or Polcalcin in Pollen-Sensitized Patients
Nicoló, M. S., Braun, T. W., Eder, K., Berghaus, A., & Gröger, M. (2016) · International Archives of Allergy and Immunology · doi:10.1159/000444279 · Cited by 29
Subiza, J. L., Feliú, A., Subiza, J. L., Uhlig, J., & Fernández-Caldas, E. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02995.x · Cited by 29
Larenas‐Linnemann, D. E., Pietropaolo-Cienfuegos, D. R., & Calderón, M. A. (2011) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2011.07.018 · Cited by 28
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs
Klimek, L., Bachmann, M. F., Senti, G., & Kündig, T. M. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.924854 · Cited by 28
Allergen Immunotherapy, Routes of Administration and Cytokine Networks: an Update
Cuppari, C., Leonardi, S., Manti, S., Filippelli, M., Alterio, T., Spicuzza, L., Rigoli, L. C., Arrigo, T., Lougaris, V., & Salpietro, C. D. (2014) · Immunotherapy · doi:10.2217/imt.14.47 · Cited by 28
Wang, K., Zheng, R., Chen, Y., Yu, Q., Zhong, H., Xiao, P., Wang, Y., & Tang, J. (2019) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2019.102280 · Cited by 28
Brown, K. R., Baker, J. R., Vereda, A., Beyer, K., Burks, A. W., Toit, G. D., Hourihane, J. O., Jones, S. M., Norval, D., Dana, A., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.12.780 · Cited by 28
Pfaar, O., van Twuijver, E., Hecker, H., Boot, J. D., van Ree, R., & Klimek, L. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000343026 · Cited by 28
Preventing progression of allergic rhinitis: the role of specific immunotherapy
Fiocchi, A. G., & Fox, A. T. (2010) · Archives of Disease in Childhood Education & Practice · doi:10.1136/adc.2010.183095 · Cited by 28
Kemp, A. S. (2009) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2009.02.002 · Cited by 28
Immunotherapy for allergies and asthma: present and future
Mohapatra, S. S., Qazi, M., & Hellermann, G. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.05.012 · Cited by 27
Are We Getting Enough Allergens?
Linneberg, A. R. (2008) · International Archives of Allergy and Immunology · doi:10.1159/000135695 · Cited by 27
The allergic march in early childhood and beyond
Linneberg, A. R. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03063.x · Cited by 27
Anagnostou, K., & Clark, A. (2014) · Clinical and Translational Allergy · doi:10.1186/2045-7022-4-30 · Cited by 22
Aini, N. R., Norhayati, M. N., Daud, M. K. M., Wise, S. K., & Abdullah, B. (2021) · Clinical and Translational Allergy · doi:10.1002/clt2.12055 · Cited by 26
On the role of allergen-specific IgG subclasses for blocking human basophil activation
Zinkhan, S., Thoms, F., Augusto, G. S., Vogel, M., & Bachmann, M. F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.892631 · Cited by 26
Short-Term Preseasonal Immunotherapy: Is Early Clinical Efficacy Related to the Basophil Response?
Özdemir, S. K., Sin, B. A., Güloğlu, D., İkincioğulları, A., Gençtürk, Z., & Mısırlıgil, Z. (2014) · International Archives of Allergy and Immunology · doi:10.1159/000365628 · Cited by 26
Justicia, J. L., Cardona, V., Guardia, P., Ojeda, P., Olaguíbel, J. M., Vega, J. M., Vidal, C., Baró, E., & Garcia, M. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.11.049 · Cited by 26
Lund, G., Willumsen, N., Holm, J., Christensen, L. H., Würtzen, P. A., & Lund, K. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.05.021 · Cited by 26
Subcutaneous Versus Sublingual Immunotherapy for Allergic Rhinitis and/or Asthma
Bahçeciler, N. N., & Çobanoğlu, N. (2011) · Immunotherapy · doi:10.2217/imt.11.48 · Cited by 26
Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety
Caminati, M., Dama, A. R., Djuric, I., Montagni, M., Schiappoli, M., Ridolo, E., Senna, G., & Canonica, G. W. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.988143 · Cited by 26
Justicia, J. L., Barasona, M. J., Serrano, P., Moreno, C., & Guerra, F. (2007) · PubMed · Cited by 26
Subcutaneous Injection Immunotherapy for Optimal Effectiveness
Nelson, H. S. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.02.010 · Cited by 25
Hancı, D., Şahin, E., Muluk, N. B., & Cingi, C. (2015) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-015-3553-5 · Cited by 25
Roche, A. M., & Wise, S. K. (2014) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21382 · Cited by 25
Aguilar‐Pimentel, J. A., Graessel, A., Alessandrini, F., Fuchs, H., Gailus‐Durner, V., de Angelis, M. H., Rußkamp, D., Chaker, A. M., Ollert, M. W., Blank, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178563 · Cited by 25
Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
Sohn, M. H. (2017) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2018.10.1.1 · Cited by 24
Aasbjerg, K., Dalhoff, K., & Backer, V. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12416 · Cited by 24
[Mexican clinical practice guidelines of immunotherapy 2011].
Larenas‐Linnemann, D. E., Ortega‐Martell, J. A., Del-Rio-Navarro, B. E., Rodríguez‐Pérez, N., Arias‐Cruz, A., Estrada, A., Becerril-Ángeles, M., Pietropaolo-Cienfuegos, D. R., Ambriz-Moreno, M. D. J., Báez-Loyola, C., et al. (2011) · PubMed · Cited by 25
Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy
Bauer, C. S., & Rank, M. A. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.024 · Cited by 24
Guidelines for practice of Allergen Immunotherapy in India
Gaur, S. N. S., Singh, B., Singh, A., Vijayan, V. K., & Agarwal, M. (2009) · Cited by 24
Current developments for improving efficacy of allergy vaccines
Sandrini, A., Rolland, J. M., & O’Hehir, R. E. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1050385 · Cited by 23
Demoly, P. M., Didier, A. P., Mathelier‐Fusade, P., Drouet, M., David, M., Bonnelye, G., Jacques de, B. L. I. C., & Klossek, J. M. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01666.x · Cited by 23
Recombinant Bet v 1 vaccine for treatment of allergy to birch pollen
Grönlund, H., & Gafvelin, G. (2010) · Human Vaccines · doi:10.4161/hv.6.12.13348 · Cited by 23
Tolerizing allergic responses in the lung
Lloyd, C. M., & Murdoch, J. R. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.19 · Cited by 23
Field, K., & Blaiss, M. S. (2020) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00934-4 · Cited by 23
Authorised allergen products for intracutaneous testing may no longer be available in Germany
Klimek, L., Werfel, T., Vogelberg, C., & Jung, K. (2015) · Allergo Journal International · doi:10.1007/s40629-015-0051-7 · Cited by 22
Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy
Matsuda, M., Terada, T., Kitatani, K., Kawata, R., & Nabe, T. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.981126 · Cited by 23
A randomized, double‐blind, placebo‐controlled trial with mannan‐conjugated birch pollen allergoids
Mösges, R., Zeyen, C., Raskopf, E., Açıkel, C., Sahin, H., Allekotte, S., Cuevas, M., Shamji, M. H., Subiza, J. L., & Casanovas, M. (2023) · Allergy · doi:10.1111/all.15910 · Cited by 22
Prevalence and treatment profile of patients with grass pollen and house dust mite allergy
Worm, M., Lee, H., & Kostev, K. (2013) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12089 · Cited by 22
Alonso‐Coello, P., Comas, D. R., Sanabria, A. J., Plaza, V., Miravitlles, M., & Martinez, L. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2013.03.004 · Cited by 22
Chaker, A. M., Al-Kadah, B., Luther, U., Neumann, U., & Wagenmann, M. (2015) · Clinical and Translational Allergy · doi:10.1186/s13601-016-0093-z · Cited by 22
Pfaar, O., Hohlfeld, J. M., Al-Kadah, B., Hauswald, B., Homey, B., Hunzelmann, N., Schliemann, S., Velling, P., Worm, M., & Klimek, L. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.12977 · Cited by 22
Approach to Patients with Allergic Rhinitis
Cox, L. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.09.001 · Cited by 22
Zeldin, Y., Weiler, Z., Magen, E., Tiosano, L., & Kidon, M. I. (2008) · PubMed · Cited by 22
Mechanism and clinical evidence of immunotherapy in allergic rhinitis
Carli, M., Capezzali, E., Tonon, S., & Frossi, B. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1217388 · Cited by 21
Klimek, L., Brehler, R., Hamelmann, E. H., Kopp, M., Ring, J., Treudler, R., Jakob, T., Worm, M., & Pfaar, O. (2019) · Allergo Journal International · doi:10.1007/s40629-019-0092-4 · Cited by 21
Calderón, M. A., Waserman, S., Bernstein, D. I., Demoly, P. M., Douglass, J. A., Gagnon, R., Katelaris, C. H., Kim, H. L., Nelson, H. S., Okamoto, Y., et al. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.04.071 · Cited by 21
Warren, C. M., Roach, A., Das, R., Casale, T. B., Vickery, B. P., Wasserman, R. L., & Gupta, R. S. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.07.020 · Cited by 21
Hundred years of allergen immunotherapy
Frew, A. J. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03768.x · Cited by 21
A comparison of immunotherapy delivery methods for allergen immunotherapy
Klimek, L., & Pfaar, O. (2013) · Expert Review of Clinical Immunology · doi:10.1586/eci.13.25 · Cited by 21
Recombinant Allergen Immunotherapy: Clinical Evidence of Efficacy—A Review
Makatsori, M., Pfaar, O., Lleonart, R., & Calderón, M. A. (2013) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0359-7 · Cited by 21
Pfaar, O., Jung, K., Wolf, H., Decot, E., Kleine‐Tebbe, J., Klimek, L., & Wüstenberg, E. G. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02801.x · Cited by 21
Is Clinical Tolerance Possible after Allergen Immunotherapy?
Moran, T. P., & Burks, A. W. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0523-3 · Cited by 21
Calderón, M. A., del Río, P. R., Vidal, C., Just, J., Pfaar, O., Linneberg, A. R., & Demoly, P. M. (2014) · Clinical and Translational Allergy · doi:10.1186/2045-7022-4-22 · Cited by 21
Makatsori, M., & Calderón, M. A. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000075 · Cited by 21
Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing
Zielen, S., Kuna, P., Aberer, W., Laßmann, S., Pfaar, O., Klimek, L., Wade, A., Kluehr, K., Raab, J., Wessiepe, D., et al. (2019) · World Allergy Organization Journal · doi:10.1016/j.waojou.2019.100075 · Cited by 21
Purkey, M. T., Smith, T. L., Ferguson, B. J., Luong, A., Reisacher, W. R., Pillsbury, H. C., & Toskala, E. M. (2013) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21141 · Cited by 20
Sublingual immunotherapy and allergic rhinitis
Cox, L. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-008-0019-5 · Cited by 20
Mösges, R., Raskopf, E., Klimek, L., Pfaar, O., Zielen, S., Xenofontos, E., Decker, L., Neuhof, C., Rybachuk, A., Açıkel, C., et al. (2024) · Allergy · doi:10.1111/all.16387 · Cited by 19
Current treatment strategies for seasonal allergic rhinitis: where are we heading?
Ridolo, E., Incorvaia, C., Pucciarini, F., Makrì, E., Paoletti, G., & Canonica, G. W. (2022) · Clinical and Molecular Allergy · doi:10.1186/s12948-022-00176-x · Cited by 21
Allergen Immunotherapy for Asthma
Kappen, J. H., Agache, I. O., Jutel, M., Pillai, P., & Corrigan, C. J. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.11.031 · Cited by 19
Predictive Biomarkers of Clinical Efficacy of Allergen-Specific Immunotherapy: How to Proceed
Shamji, M. H., Lj⊘rring, C., & Würtzen, P. A. (2013) · Immunotherapy · doi:10.2217/imt.13.6 · Cited by 19
Pfaar, O., Sager, A., & Robinson, D. S. (2015) · Pediatric Allergy and Immunology · doi:10.1111/pai.12347 · Cited by 19
Gödicke, V., & Hundt, F. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02436.x · Cited by 19
Anolik, R. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902980187 · Cited by 17
Harmancı, K., Razi, C. H., Toyran, M., Kanmaz, G., & Cengizlier, M. R. (2010) · PubMed · Cited by 18
van der Valk, J., Nagl, B., van Wljk, R. G., Bohle, B., & de Jong, N. W. (2020) · Nutrients · doi:10.3390/nu12020519 · Cited by 18
Stylianou, E., Ueland, T., Borchsenius, F., Michelsen, A. E., Øvstebø, R., Mollnes, T. E., Skjønsberg, O. H., & Aukrust, P. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2015.1110856 · Cited by 18
Physicians' experience and opinion on contraindications to allergen immunotherapy: The CONSIT survey
del Río, P. R., Pitsios, C., Tsoumani, M., Pfaar, O., Paraskevopoulos, G., Gawlik, R., Valovirta, E. J., Larenas‐Linnemann, D. E., Demoly, P. M., & Calderón, M. A. (2017) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2017.02.012 · Cited by 18
Guidelines for practice of allergen immunotherapy in India: 2017-An update
Gaur, S., Kumar, R., Singh, A., Agarwal, M., & Arora, N. (2017) · Indian Journal of Allergy Asthma and Immunology · doi:10.4103/ijaai.ijaai_10_17 · Cited by 18
Immunotherapy for pet allergies
Virtanen, T. I. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1409315 · Cited by 18
Novel strategies for the treatment of grass pollen-induced allergic rhinitis
Larsson, O., Hellkvist, L., Peterson-Westin, U., & Cardell, L. O. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1190829 · Cited by 16
Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
Dhami, S., Nurmatov, U. B., Roberts, G. C., Pfaar, O., Muraro, A. M., Ansotegui, I. J., Calderón, M. A., Cingi, C., Demoly, P. M., Durham, S. R., et al. (2016) · Clinical and Translational Allergy · doi:10.1186/s13601-016-0099-6 · Cited by 17
Self-citationde Bot, C. M., Moed, H. D., Berger, M. Y., Röder, E., de Groot, H., de Jongste, J. C., van Wijk, R. G., & van der Wouden, J. C. (2008) · BMC Family Practice · doi:10.1186/1471-2296-9-59 · Cited by 17
GEMA (Guía española del manejo del asma)
(2009) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(09)73459-3 · Cited by 18
Mechanisms and Treatment of Type 2 High and Low Asthma Endotypes
Chin‐See‐Chong, T. C., Kappen, J. H., Palmer, E. N., Layhadi, J. A., Shamji, M. H., & van der Valk, J. P. M. (2025) · Clinical & Experimental Allergy · doi:10.1111/cea.70084 · Cited by 16
Aljuaid, E., Assiri, S. A., Althaqafi, R. M. M., Alsufyani, A., & Alghamdi, A. S. A. (2021) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1016/j.wjorl.2020.12.001 · Cited by 15
Villa, R. C., Uribe-García, S., Calvo, V., Cantillo, J. F., & Fernández‐Caldas, E. (2022) · World Allergy Organization Journal · doi:10.1016/j.waojou.2022.100692 · Cited by 16
Structures and Anti-Allergic Activities of Natural Products from Marine Organisms
Chen, N., Zhang, S., Javeed, A., Jian, C., Liu, Y., Sun, J., Wu, S., Fu, P., & Han, B. (2023) · Marine Drugs · doi:10.3390/md21030152 · Cited by 16
Vance, G. H. S., Goldring, S., Warner, J. O., Cox, H. E., Sihra, B. S., Hughes, S. M., Gardner, J., North, J., Roberts, G. C., Proudfoot, C., et al. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03803.x · Cited by 16
Development of a sublingual allergy vaccine for grass pollinosis
Incorvaia, C. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s10044 · Cited by 16
Allergen immunotherapy practice patterns: a worldwide survey
Ponda, P., Mithani, S., Kopyltsova, Y., Sison, C. P., Gupta, P., Larenas‐Linnemann, D. E., & Bonagura, V. R. (2012) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2012.04.002 · Cited by 16
Pfaar, O., Mösges, R., Hörmann, K., & Klimek, L. (2009) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-009-1077-6 · Cited by 16
Metadata
- Authors
- Calderon, M. A., Alves, B., Jacobson, M., Hurwitz, B., Sheikh, A., & Durham, S.
- Affiliations
- Royal Brompton Hospital; Department of Allergy and Respiratory Medicine; Imperial College School of Medicine at the National Heart and Lung Institute London UK SW3 6LY
- Brighton and Hove City Council (GB)
- Imperial College London (GB)
- King's College London (GB)
- University of Edinburgh (GB)
- Royal Brompton Hospital (GB)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2007-01-24
- Volume
- 2009
- Issue
- 1
- Pages
- CD001936-CD001936
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC7017974
- OpenAlex
- W2153011983
- Cited by
- 678
- References
- 321
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 17 · 2023: 20 · 2022: 31 · 2021: 14 · 2020: 19 · 2019: 24 · 2018: 34 · 2017: 38 · 2016: 41 · 2015: 53 · 2014: 51 · 2013: 50 · 2012: 53
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- allergen immunotherapy, allergic rhinitis, tree pollen, grass pollen, weed pollen, symptom scores, medication use, quality of life, adverse events, placebo comparison, treatment efficacy and safety, treatment duration, allergen sensitivity, allergen avoidance, allergen desensitization, allergen tolerance
- MeSH terms
- Allergens, Desensitization, Immunologic, Rhinitis, Allergic, Seasonal, Humans, Injections, Subcutaneous, Pollen, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
